Search Results - "CANNONI, S"

Refine Results
  1. 1

    Riluzole in cerebellar ataxia: A randomized, double-blind, placebo-controlled pilot trial by RISTORI, G, ROMANO, S, VISCONTI, A, CANNONI, S, SPADARO, M, FRONTALI, M, PONTIERI, F. E, VANACORE, N, SALVETTI, M

    Published in Neurology (09-03-2010)
    “…The pleiotropic effects of riluzole may antagonize common mechanisms underlying chronic cerebellar ataxia, a debilitating and untreatable consequence of…”
    Get full text
    Journal Article
  2. 2

    Epstein–Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins by Mechelli, R, Anderson, J, Vittori, D, Coarelli, G, Annibali, V, Cannoni, S, Aloisi, F, Salvetti, M, James, JA, Ristori, G

    Published in Multiple sclerosis (01-11-2011)
    “…Background: Compared with quantitative observations, the search for qualitative changes that may characterize the immune response to Epstein–Barr virus (EBV)…”
    Get full text
    Journal Article
  3. 3

    When a pregnancy required a neurological consultation: a case report by Ferraldeschi, M, Tari Capone, F, Di Lisi, F, Patella, R, Ceschim, V, Cao, M, Cannoni, S, Rasura, M

    Published in Clinica terapeutica (01-11-2012)
    “…Posterior reversible encephalopathy syndrome (PRES) is a transient clinical and neuroradiological syndrome characterized by clinical signs and symptoms…”
    Get more information
    Journal Article
  4. 4

    Multiple sclerosis: pharmacogenomics and personalised drug treatment by Annibali, V, Ristori, G, Cannoni, S, Romano, S, Visconti, A, Ghazaryan, A, Figà Talamanca, L, Salvetti, M, Mechelli, R

    Published in Neurological sciences (01-09-2006)
    “…Multiple sclerosis (MS) is a disorder of the central nervous system with an inflammatory and a neurodegenerative component. We do not yet have a definitive…”
    Get full text
    Journal Article
  5. 5

    Physiopathology of multiple sclerosis by Visconti, A, Santucci, S, Figà Talamanca, L, Cannoni, S, Ristori, G, Salvetti, M

    Published in Neurological sciences (01-12-2003)
    “…Pleiotropy and redundancy are distinctive elements of the immune response. Recent research into the inflammatory component of multiple sclerosis (MS) indicates…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Characterization of CD8+ T cell repertoire in identical twins discordant and concordant for multiple sclerosis by Somma, Paolo, Ristori, Giovanni, Battistini, Luca, Cannoni, Stefania, Borsellino, Giovanna, Diamantini, Adamo, Salvetti, Marco, Sorrentino, Rosa, Fiorillo, Maria Teresa

    Published in Journal of leukocyte biology (01-03-2007)
    “…Autoreactive CD4+ and CD8+ T cells directed against CNS autoantigens may play a role in the development of multiple sclerosis (MS). Identical twins share the…”
    Get full text
    Journal Article
  10. 10

    Cerebrospinal fluid isoprostanes are not related to inflammatory activity in relapsing–remitting multiple sclerosis by Greco, Anita, Minghetti, Luisa, Puopolo, Maria, Cannoni, Stefania, Romano, Silvia, Pozzilli, Carlo, Levi, Giulio

    Published in Journal of the neurological sciences (15-09-2004)
    “…Oxidative stress leads to lipid peroxidation and may contribute to the pathogenesis of lesions in multiple sclerosis (MS), an autoimmune disease characterised…”
    Get full text
    Journal Article
  11. 11

    Protein tyrosine phosphatase receptor-type C exon 4 gene mutation distribution in an Italian multiple sclerosis population by Ballerini, Clara, Rosati, Eleonora, Salvetti, Marco, Ristori, Giovanni, Cannoni, Stefania, Biagioli, Tiziana, Massacesi, Luca, Sorbi, Sandro, Vergelli, Marco

    Published in Neuroscience letters (16-08-2002)
    “…In this study, we investigate the role of the C→G mutation in position 77 of exon 4 of the protein tyrosine phosphatase receptor-type C (PTPRC) gene, coding…”
    Get full text
    Journal Article
  12. 12

    Epidemiology and current treatment of multiple sclerosis in Europe today by Pozzilli, Carlo, Romano, Silvia, Cannoni, Stefania

    “…Multiple sclerosis (MS) is a chronic disease affecting the central nervous system, usually leading to early disablement in young adults. At least 350,000…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Gene expression profiles reveal homeostatic dynamics during interferon- sub( beta ) therapy in multiple sclerosis by Annibali, V, Di Giovanni, S, Cannoni, S, Giugni, E, Bomprezzi, R, Mattei, C, Elkahloun, A, Coccia, E M, Alfo, M, Orzi, F, Ristori, G, Salvetti, M

    Published in Autoimmunity (Chur, Switzerland) (01-01-2007)
    “…Understanding the mechanisms that sustain the effects of disease modifying drugs in multiple sclerosis (MS) may help refine current therapies and improve our…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    T cell response to myelin basic protein before and after treatment with interferon beta in multiple sclerosis by Ristori, Giovanni, Montesperelli, Chiara, Gasperini, Claudio, Battistini, Luca, Borsellino, Giovanna, Buttinelli, Carla, Cannoni, Stefania, Perna, Alessia, Pozzilli, Carlo, Salvetti, Marco

    Published in Journal of neuroimmunology (01-09-1999)
    “…Studies on the in vivo effects of interferon-β (IFNβ) therapy on autoreactive T cells have never been carried out in multiple sclerosis (MS). We investigated…”
    Get full text
    Journal Article
  20. 20

    T cell response to N‐formylated peptides in humans by Ristori, Giovanni, Montesperelli, Chiara, Fiorillo, Maria Teresa, Battistini, Luca, Chersi, Alberto, Sorrentino, Rosa, Borsellino, Giovanna, Perna, Alessia, Tramonti, Daniela, Cannoni, Stefania, Perrone, Maria Paola, Giubilei, Franco, Riccio, Paolo, Salvetti, Marco, Buttinelli, Carla

    Published in European journal of immunology (01-09-2001)
    “…We present the first evidence of a T lymphocyte response to N‐formylated peptides in humans. N‐formylated peptide sequences from self (mitochondrial) and…”
    Get full text
    Journal Article